Month: <span>June 2023</span>

Home / 2023 / June
Fungal infections an unintended consequence of advanced immunotherapy, research shows
Post

Fungal infections an unintended consequence of advanced immunotherapy, research shows

by Hackensack Meridian Health Graphical abstract. Credit: Cell (2023). DOI: 10.1016/j.cell.2023.04.031 Major fungal infections have become more common across the globe, and one unexpected phenomenon among the rise of fungi is life-threatening infections as a result of a complication of certain immunotherapies and small molecule kinase inhibitors. A scientist at the Hackensack Meridian Center for Discovery and...

A Rare Form of Dementia Can Unleash Creativity
Post

A Rare Form of Dementia Can Unleash Creativity

By Robert Martone on May 26, 2023 Credit: Sean Gladwell/Getty Images Neurological conditions can release a torrent of new creativity in a few people as if opening some mysterious floodgate. Auras of migraine and epilepsy may have influenced a long list of artists, including Pablo Picasso, Vincent van Gogh, Edvard Munch, Giorgio de Chirico, Claude Monet and Georges Seurat. Traumatic...

Healthcare costs top $31,000 for family of 4 in 2023
Post

Healthcare costs top $31,000 for family of 4 in 2023

Published June 1, 2023 By Emily Olsen 9dreamstudio via Getty Images Dive Brief: Healthcare costs for a hypothetical family of four covered under an average employer-sponsored preferred provider organization plan will rise to $31,065 in 2023, according to the Milliman Medical Index.  Increasing costs are a long-term trend in healthcare, though the MMI noted expenses decreased for the first...

Post

FDA approves Pfizer’s RSV shot for older adults, teeing up a competitive $17B vaccine market

Andrew Dunn Biopharma Correspondent The FDA approved Pfizer’s RSV vaccine called Abrysvo for older adults on Wednesday, placing another Big Pharma onto the commercial stage ahead of the next RSV season. Pfizer’s approval comes weeks after GSK won approval for its rival shot, Arexvy. Those two vaccines are both approved for use in adults 60...

Post

FDA warns about compounded semaglutide-based drugs

Tyler Patchen News Reporter The FDA has warned the public that compounded versions of popular GLP-1 drugs Ozempic and Wegovy may not include the same ingredients as the prescription medications, and that has raised questions about their safety and effectiveness. The regulator said Tuesday it has received reports of adverse events related to compounded versions...

New health indicator can revolutionize how we measure and achieve well-being
Post

New health indicator can revolutionize how we measure and achieve well-being

FRONTIERS IMAGE: ‘HUMAN FUNCTIONING’ COMPLEMENTS MORBIDITY AND MORTALITY TO PROVIDE A HOLISTIC UNDERSTANDING OF HUMAN HEALTH THAT GOES BEYOND DISEASE CREDIT: FRONTIERS/SWISS PARAPLEGIC RESEARCH AND THE UNIVERSITY OF LUCERNE The term ‘well-being’ entered popular vocabulary during the Covid-19 pandemic soon after ‘lockdown’ and ‘quarantine’. We quickly discovered that without the ability to take walks, socialize,...

Post

Cardiovascular considerations in RA

EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY (EULAR) The increased cardiovascular risks in RA include acute coronary syndromes (ACS). The extent to which DMARD-induced remission could reduce the risk of ACS in RA versus rates in the general population – and whether there are DMARD-specific beneficial effects on ACS risk – remain unknown. In a session...

Ketamine nasal spray may a prove safe and effective treatment for refractory migraine
Post

Ketamine nasal spray may a prove safe and effective treatment for refractory migraine

by British Medical Journal Credit: Pixabay/CC0 Public Domain Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single center study, published in Regional Anesthesia & Pain Medicine. It’s a more convenient alternative to intravenous infusion—the usual method of administration for these patients—but the potential for overuse means...

Post

Probiotics Raise Concerns in Vulnerable Populations

Giuliana Miranda May 25, 2023 In a study published in the journal Gut Microbes , specialists affiliated with the International Scientific Association for Probiotics and Prebiotics (ISAPP) raised questions regarding the safety of probiotics, especially among vulnerable populations (such as newborns, pregnant women, patients with short bowel syndrome, and patients who are immunocompromised). Despite theoretical and proven adverse events from probiotic...